{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:17:40Z","timestamp":1791137860643,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":472,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.stem.2012.02.017","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T16:45:36Z","timestamp":1333644336000},"page":"412-424","source":"Crossref","is-referenced-by-count":210,"title":["Genetic and Pharmacologic Inhibition of \u03b2-Catenin Targets Imatinib-Resistant Leukemia Stem Cells in CML"],"prefix":"10.1016","volume":"10","author":[{"given":"Florian\u00a0H.","family":"Heidel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bullinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias\u00a0A.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios","family":"Kalaitzidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven\u00a0W.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott\u00a0A.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2012.02.017_bib1","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1200\/JCO.2009.25.4011","article-title":"Emerging targeted therapies for breast cancer","volume":"28","author":"Alvarez","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.stem.2012.02.017_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1749-6632.2000.tb06698.x","article-title":"Control of beta-catenin signaling in tumor development","volume":"910","author":"Behrens","year":"2000","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.stem.2012.02.017_bib3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1126\/science.280.5363.596","article-title":"Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta","volume":"280","author":"Behrens","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.stem.2012.02.017_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","article-title":"The chronic myelogenous leukemia-specific P210 protein is the product of the bcr\/abl hybrid gene","volume":"233","author":"Ben-Neriah","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.stem.2012.02.017_bib5","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.1116221","article-title":"Prostaglandin E2 promotes colon cancer cell growth through\u00a0a Gs-axin-beta-catenin signaling axis","volume":"310","author":"Castellone","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.stem.2012.02.017_bib6","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/leu.2009.52","article-title":"Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice","volume":"23","author":"Chen","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2012.02.017_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive\u00a0to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.stem.2012.02.017_bib8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.stem.2012.02.017_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1470-2045(10)70209-6","article-title":"KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer","volume":"12","author":"De Roock","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.stem.2012.02.017_bib10","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.stem.2012.02.017_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2012.02.017_bib12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2012.02.017_bib13","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1200\/JCO.2010.28.9678","article-title":"Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3","volume":"28","author":"Fischer","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.stem.2012.02.017_bib14","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1182\/blood-2009-03-205823","article-title":"In\u00a0vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells","volume":"114","author":"Frisch","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.stem.2012.02.017_bib15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2009.01.015","article-title":"Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration","volume":"136","author":"Goessling","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.stem.2012.02.017_bib16","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood.V92.8.2641","article-title":"Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic\/severe combined immune-deficient mice","volume":"92","author":"Gothot","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.stem.2012.02.017_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1056\/NEJM199707243370402","article-title":"Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia","volume":"337","author":"Guilhot","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2012.02.017_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35094017","article-title":"Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2","volume":"1","author":"Gupta","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.stem.2012.02.017_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood-2005-06-2469","article-title":"Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain","volume":"107","author":"Heidel","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.stem.2012.02.017_bib20","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.4049\/jimmunol.0802413","article-title":"Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2","volume":"182","author":"Higashi","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.stem.2012.02.017_bib21","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1182\/blood-2009-01-201335","article-title":"Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation","volume":"113","author":"Hoggatt","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.stem.2012.02.017_bib22","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1634\/stemcells.2007-0600","article-title":"Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth","volume":"26","author":"Holmes","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.stem.2012.02.017_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","article-title":"beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia","volume":"23","author":"Hu","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2012.02.017_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.stem.2012.02.017_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2012.02.017_bib26","doi-asserted-by":"crossref","first-page":"e3776","DOI":"10.1371\/journal.pone.0003776","article-title":"Flow-cytometric phosphoprotein analysis reveals agonist and temporal differences in responses of murine hematopoietic stem\/progenitor cells","volume":"3","author":"Kalaitzidis","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.stem.2012.02.017_bib27","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","article-title":"Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia","volume":"362","author":"Kantarjian","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2012.02.017_bib28","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/ni1381","article-title":"Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block","volume":"7","author":"Kirstetter","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.stem.2012.02.017_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood-2007-07-099754","article-title":"Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis","volume":"111","author":"Koch","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.stem.2012.02.017_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-59745-418-6_11","article-title":"Gene expression profiling of leukemia stem cells","volume":"538","author":"Krivtsov","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.stem.2012.02.017_bib31","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2009-11-251728","article-title":"The Apc(min) mouse has altered hematopoietic stem cell function and provides a model for MPD\/MDS","volume":"115","author":"Lane","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.stem.2012.02.017_bib32","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/leu.2011.154","article-title":"Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroups","volume":"25","author":"L\u00fcck","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2012.02.017_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.stem.2011.07.017","article-title":"Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion","volume":"9","author":"Luis","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2012.02.017_bib34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.stem.2012.02.017_bib35","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1073\/pnas.0900089106","article-title":"Dysregulated gene expression networks in human acute myelogenous leukemia stem cells","volume":"106","author":"Majeti","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stem.2012.02.017_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.stem.2008.12.004","article-title":"Wnt-related molecules and signaling pathway equilibrium in hematopoiesis","volume":"4","author":"Malhotra","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2012.02.017_bib37","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1038\/leu.2009.151","article-title":"The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia","volume":"23","author":"Mason","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2012.02.017_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1182\/blood-2009-03-210732","article-title":"A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib","volume":"115","author":"McWeeney","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.stem.2012.02.017_bib39","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/MCB.24.7.2890-2904.2004","article-title":"Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells","volume":"24","author":"M\u00fcller-Tidow","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.stem.2012.02.017_bib40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1365-2362.2002.01004.x","article-title":"Molecular causes of colon cancer","volume":"32","author":"Oving","year":"2002","journal-title":"Eur. J.\u00a0Clin. Invest."},{"key":"10.1016\/j.stem.2012.02.017_bib41","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1084\/jem.20050967","article-title":"Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates","volume":"202","author":"Passegu\u00e9","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.stem.2012.02.017_bib42","doi-asserted-by":"crossref","unstructured":"Peterson, L.F., Turbiak, A.T., Giannola, D.M., Donato, N., Showalter, H.D., Fearon, E.R., and Talpaz, M. (2009). Wnt-Pathway Directed Compound Targets Blast Crisis and Chronic Phase CML Leukemia Stem Progenitors. Blood (ASH Annual Meeting Abstracts) 114, 2168.","DOI":"10.1182\/blood.V114.22.2168.2168"},{"key":"10.1016\/j.stem.2012.02.017_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature01593","article-title":"A role for Wnt signalling in self-renewal of haematopoietic stem cells","volume":"423","author":"Reya","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.stem.2012.02.017_bib44","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/leu.2010.185","article-title":"Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR","volume":"24","author":"Ross","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2012.02.017_bib45","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.stem.2012.02.017_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.stem.2012.02.017_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2006-03-011239","article-title":"Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years","volume":"109","author":"Rousselot","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.stem.2012.02.017_bib48","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1126\/science.272.5264.1023","article-title":"Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly","volume":"272","author":"Rubinfeld","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.stem.2012.02.017_bib49","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Saglio","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2012.02.017_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc2368","article-title":"Getting to the stem of chronic myeloid leukaemia","volume":"8","author":"Savona","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.stem.2012.02.017_bib51","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ni1387","article-title":"Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation","volume":"7","author":"Scheller","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.stem.2012.02.017_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nm1339","article-title":"Glycogen synthase kinase-3 is an in\u00a0vivo regulator of hematopoietic stem cell repopulation","volume":"12","author":"Trowbridge","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2012.02.017_bib53","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nature07284","article-title":"Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy","volume":"455","author":"Wang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.stem.2012.02.017_bib54","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","article-title":"The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.stem.2012.02.017_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of beta-catenin impairs the renewal of normal and CML stem cells in\u00a0vivo","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590912000768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590912000768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T13:54:00Z","timestamp":1593957240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590912000768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1934590912000768"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2012.02.017","relation":{},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}